The amount and location of microbleeds – tiny areas of damage in the brain – may serve as indicators of dementia risk, according to an observational analysis published this week.
Researchers have long known that these microbleeds, often visible on MRI scans, are associated with cerebrovascular disease and cognitive decline. The latest analysis suggests a more nuanced relationship, indicating that the specific areas where these bleeds occur could be particularly telling. Although the study did not establish a causal link, it reinforces the growing understanding of vascular contributions to dementia.
The findings come as the medical community continues to explore preventative measures against dementia, including cognitive training. A large, long-term study released earlier this month found that engaging in a specific type of brain training game – “speed training” – for up to 23 hours over three years was associated with a 25% lower risk of developing Alzheimer’s and other dementias over a 20-year follow-up period. The study, a follow-up to the earlier ACTIVE trial funded by the National Institutes of Health, involved nearly 3,000 participants aged 65 and older.
“It’s very surprising,” said Marilyn Albert, director of the Johns Hopkins Alzheimer’s Disease Research Center, commenting on the brain training study. “It’s not at all what I would have expected.”
Dementia itself is characterized by a decline in cognitive function, impacting memory, thinking, problem-solving, and language. It is caused by diseases that damage the brain, such as Alzheimer’s disease or strokes, and is a progressive condition, meaning symptoms worsen over time. Currently, there is no cure for most forms of dementia.
Recent research has also explored potential links between lifestyle factors and brain health. Medical News Today reported on ongoing investigations into the impact of diet, including the potential effects of artificial sweeteners and the benefits of the Mediterranean diet. A report from MedPage Today highlighted recent findings regarding diet soda and dementia, alongside updates on migraines and brain cancer.
The implications of the microbleed analysis are still being investigated, and further research is needed to determine whether identifying and monitoring these brain lesions could lead to earlier diagnosis or targeted interventions. No immediate clinical guidelines have been issued based on the findings.
